Advertisement
Screener

BIOMERICA INC (BMRA) Equity Method Investment, Ownership Percentage

2.4 / 5 stars · 56/119 Roast Me

BIOMERICA INC Equity Method Investment, Ownership Percentage

BIOMERICA INC (BMRA) had Equity Method Investment, Ownership Percentage of 6.00% as of 2022-02-28, per its 10-Q filed 2022-04-14.

Discontinued › Notes

us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2022-04-14

  • 2022-02-28: Equity Method Investment, Ownership Percentage 6.00%.
  • 2021-11-30: Equity Method Investment, Ownership Percentage 6.00%.
  • 2021-08-31: Equity Method Investment, Ownership Percentage 6.00%.
  • 2021-05-31: Equity Method Investment, Ownership Percentage 6.00%.
Period endEquity Method Investment, Ownership Percentage
2022-02-286.00%
10-Q · filed 2022-04-14
2021-11-306.00%
10-Q · filed 2022-01-12
2021-08-316.00%
10-Q · filed 2021-10-14
2021-05-316.00%
10-K/A · filed 2021-10-14
2021-02-286.00%
10-Q · filed 2021-04-14
2020-11-306.00%
10-Q · filed 2021-01-14
2020-08-316.00%
10-Q · filed 2020-10-15
2020-05-316.00%
10-K · filed 2020-08-31
2020-02-296.00%
10-Q · filed 2020-04-14
2019-11-306.00%
10-Q · filed 2020-01-14
2019-08-316.00%
10-Q · filed 2019-10-15
2019-05-316.00%
10-K · filed 2019-08-29
2019-02-286.00%
10-Q · filed 2019-04-15
2014-11-306.00%
10-Q · filed 2015-01-14
2014-08-316.00%
10-Q · filed 2014-10-15
2014-02-286.00%
10-Q · filed 2014-04-14
2013-11-306.00%
10-Q · filed 2014-01-14
2013-08-316.00%
10-Q · filed 2013-10-15
2013-05-316.00%
10-K · filed 2013-08-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92